enVVeno Medical (NVNO) Gains from Investment Securities (2017 - 2026)

enVVeno Medical's Gains from Investment Securities history runs 10 years deep, the most recent figure standing at -$4000.0 for Q1 2026.

• In Q1 2026, Gains from Investment Securities changed N/A year-over-year to -$4000.0; the TTM figure through Dec 2025 stood at $33000.0 (down 5.71% YoY), while the FY2025 annual figure was $33000.0, down 5.71% from the prior year.
• Gains from Investment Securities was -$4000.0 for Q1 2026 at enVVeno Medical, down from $33000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $529.0 million in Q2 2025 to a low of -$4000.0 in Q1 2026.
• Historically, Gains from Investment Securities has averaged $83.4 million across 5 years, with a median of $102500.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities tumbled 96.42% in 2023, then soared 445163.16% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at $3.8 million in 2022, then sank by 96.42% to $136000.0 in 2023, then sank by 74.26% to $35000.0 in 2024, then fell by 5.71% to $33000.0 in 2025, then slumped by 112.12% to -$4000.0 in 2026.
• The last three Gains from Investment Securities figures came in at -$4000.0 (Q1 2026), $33000.0 (Q4 2025), and $529.0 million (Q2 2025), per Business Quant data.